$TATT

TAT Technologies Stock Jumps 18% On Q2 Earnings And Revenue Growth

TAT Technologies Ltd. (TATT) shares rose about 18% to $49.08 on Wednesday after the company reported Q2 results. Net earnings increased to $8.07 million, or $0.61 per share, from $3.44 million, or $0.30 per share, a year earlier. Revenue grew 22.8% to $52.94 million. The stock traded on Nasdaq between $48.90 and $52.99.

Original reporting
Published Aug 5, 2026, 3:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TAT Technologies Stock Jumps 18% On Q2 Earnings And Revenue Growth — source image
Decision brief

The 30-second read

$TATTBullishMed
01

Why it matters

The disclosed year-over-year improvement in net earnings and revenue is a fresh fundamental catalyst that can drive momentum trading and re-rate expectations for near-term performance.

02

Market read

Traders can use the reported Q2 earnings and revenue growth as the immediate catalyst for positioning, but should verify whether guidance or margin/backlog details support follow-through.

03

What to watch

The piece lacks guidance, backlog, cash flow, and segment performance; traders may need those to judge whether the revenue growth is durable or one-off.

Relevance 8/10Novelty 7/10Timing: same-day after-hours/next-session positioning following Q2 results reported today

Background

The article reports TAT Technologies’ Q2 results and ties them to a large same-session price jump on the Nasdaq.

Company-level read

Ticker impact

$TATTBullishMedium confidence
Context

TAT Technologies shares jumped after Q2 net earnings and revenue rose year over year, with revenue up 22.8% to $52.94M.

Expected impact

Likely continued volatility and follow-through buying early, but direction beyond the initial reaction depends on any guidance or margin details not included here.

Evidence & confidence

The article provides concrete Q2 EPS and revenue growth figures tied to the same-day price surge, but omits guidance, margins, backlog, or management commentary that would determine follow-through.

Market effects

Aerospace and defense services names may see sentiment lift when smaller operators report double-digit revenue growth, though no sector-wide data is provided here.

Primarily US Nasdaq small/mid-cap sentiment impact; no broader regional linkage is described.

No global macro or international contract details are included, limiting spillover beyond the issuer.

Counterpoint

The stock’s move could fade if the quarter’s adjusted earnings and margins are not strong enough to sustain growth, especially since adjusted EPS is lower than GAAP EPS in the article.

Key entities

  • TAT Technologies Ltd.

    Aerospace and defense services company reporting Q2 earnings and revenue growth that coincided with an 18% stock jump.

Related articles

Med

TAT Technologies Ltd. Q2 2026 Earnings Call Summary

TAT Technologies Ltd. reported Q2 2026 revenue up 23% and a record $650 million backlog, citing improved supply conditions. The company expanded its Honeywell Aerospace spare-parts distribution deal for the 331-200/250 APU through 2036. Management said profitability was temporarily pressured by inventory investment and higher procurement costs, while working capital stays elevated. Nonrecurring items included a $4.3M gross gain and a $900k tax charge.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.